MarketBeat cites USD 19.46 target for Bausch + Lomb stock

Published on 10/20/2026 at 22:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 1.39 billion, up 9.10 percent. Bausch + Lomb stock costs EUR 15.00 on October 20, 2026 at 9:53 p.m. CEST.

Analyst Target and Results Date

MarketBeat reported a USD 19.46 average 12-month price target on October 17, 2026.
Second-quarter revenue reached USD 1.39 billion, up 9.10 percent year over year.
Bausch + Lomb stock costs EUR 15.00 at Lang & Schwarz on October 20, 2026 at 9:53 p.m. CEST.
Third-quarter 2026 results are scheduled for October 28, 2026.

BLCO, CA0717051076, Illustration mit AI erstellt.

Bausch + Lomb Corporation (ISIN CA0717051076) had an average 12-month price target of USD 19.46 in a MarketBeat report dated October 17, 2026. The report described a Hold consensus from 15 brokerages, including seven hold, six buy, one strong-buy and one sell rating. The target lies 15.08 percent above the latest USD 16.91 home-market price. Bausch + Lomb was trading at EUR 15.00 at Lang & Schwarz on October 20, 2026 at 9:53 p.m. CEST.

Revenue remains the key operating figure

MarketBeat said Bausch + Lomb reported second-quarter revenue of USD 1.39 billion, up 9.10 percent from USD 1.28 billion in the same period a year earlier. The figure exceeded the USD 1.37 billion consensus estimate, while earnings per share came in at USD 0.15 against a USD 0.16 consensus estimate, according to MarketBeat on October 17, 2026.

Stock remains inside its yearly range

The USD 16.91 NYSE price at 3:58 p.m. ET on October 20, 2026 sat between the 52-week low of USD 14.44 and the 52-week high of USD 18.92. The latest quote implies a market capitalization of USD 6.0 billion and a price-to-earnings ratio of minus 35.34. These figures place the stock 10.62 percent below its 52-week high and 17.10 percent above its 52-week low.

Results date adds the next fixed marker

Bausch + Lomb's investor-relations page lists third-quarter 2026 financial results for October 28, 2026, with the release and investor call scheduled for 8:00 a.m. ET. The company describes itself as a global eye-health business serving vision care, pharmaceuticals and surgical applications. Its listing is identified as NYSE and TSX: BLCO on the investor-relations page.

What the target implies for valuation

The USD 19.46 consensus target is 15.08 percent above the USD 16.91 NYSE price, using the same currency for both values. The comparison does not change the separate euro quotation at Lang & Schwarz, which is the price German investors see in this report. The next earnings release should provide the next reported comparison for revenue, earnings per share and operating execution.

Price and reporting date

Bausch + Lomb stock was trading at EUR 15.00 at Lang & Schwarz on October 20, 2026 at 9:53 p.m. CEST. The next scheduled financial event is the third-quarter 2026 results release on October 28, 2026. The further course of trading is shown by the continuously updated real-time quote of Bausch + Lomb stock.